The once-heralded blood-testing company Theranos received a letter from the Centers for Medicare & Medicaid Services this week outlining key areas in which its laboratory fails to meet federal guidelines. The notice, which is dated Monday, requires the company to bring itself into compliance within 10 calendar days of its receipt.